RESEARCH FUNDER

National Institutes of Health (NIH)

Share

The National Institutes of Health (NIH) is the primary agency funded by the US government for biomedical and public health research. The Institutes provide extramural research funding for biomedical researchers, primarily in the USA and some awards for international researchers.

Open Access Policy: The NIH Public Access policy requires that all grantees submit or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final, peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. Publication costs, including author fees, may be charged to NIH grants and contracts on three conditions: (1) such costs incurred are actual, allowable, and reasonable to advance the objectives of the award; (2) costs are charged consistently regardless of the source of support; (3) all other applicable rules on allowability of costs are met.

Funder location: 
Activity location: 
Recipient citizenship: 

Related Grant Opportunities

Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (USA)

Letter of intent: July 13, 2024

Final closing date: August 13, 2024

International Research in Infectious Diseases (developing countries)

Letter of intent: July 2, 2024

Final closing date: August 2, 2024

NIMH Short Courses for Mental Health Related Research (USA)

Letter of intent: April 25, 2024

Final closing date: May 25, 2024

NIMH Research Education Programs for Psychiatry Residents (USA)

Letter of intent: April 25, 2024

Final closing date: May 25, 2024

NIMH Mentoring Networks for Mental Health Research Education (USA)

Letter of intent: April 25, 2024

Final closing date: May 25, 2024

Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)

Letter of intent: December 26, 2023

Final closing date: January 26, 2024

NCI Outstanding Investigator Award (Cancer Research USA)

Letter of intent: October 7, 2023

Final closing date: November 7, 2023

Tobacco Regulatory Science (R01 Clinical Trial Optional)

Letter of intent: August 6, 2023

Final closing date: October 6, 2023

Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed)

Letter of intent: September 4, 2023

Final closing date: October 4, 2023

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Letter of intent: September 1, 2023

Final closing date: October 2, 2023

Comparative Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: August 13, 2023

Final closing date: September 27, 2023

Genomic Community Resources (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 25, 2023

Final closing date: September 25, 2023

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed | USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: August 25, 2023

Final closing date: September 25, 2023

Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: August 22, 2023

Final closing date: September 22, 2023

NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: September 8, 2023

Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 25, 2023

Final closing date: August 25, 2023

Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 10, 2023

Final closing date: August 10, 2023

Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 9, 2023

Final closing date: August 9, 2023

Ruth L. Kirschstein Individual Predoctoral NRSA for MD/PhD and other Dual Degree Fellowships (USA biomedical research)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: August 8, 2023

Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: July 2, 2023

Final closing date: August 2, 2023

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: June 28, 2023

Final closing date: July 28, 2023

HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: June 10, 2023

Final closing date: July 10, 2023

Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed) (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: June 7, 2023

Final closing date: July 7, 2023

Roybal Centers for Translational Research on Aging (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: May 23, 2023

Final closing date: June 23, 2023

Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional) (worldwide)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Letter of intent: May 20, 2023

Final closing date: June 20, 2023

Support for Research Excellence (SuRE) Award (USA)

The opportunity is currently closed. Sign-up for grant alerts to be informed when the grant re-opens.

Final closing date: May 26, 2023

Funder Perspective

No related blog.

Funder Event

Would you like to be included in our database?

Get in touch

data base inclusion

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.